Ameritas Advisory Services’s Thermo Fisher Scientific TMO Stock Holding History

Ameritas Advisory Services’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.3M	Sell	4,674 -109	-2%	-$59.2K	0.09%	205
2025 Q4	$2.77M	Buy	4,783 +4,018	+525%	+$2.27M	0.1%	178
2025 Q3	$371K	Sell	765 -3,226	-81%	-$1.5M	0.02%	473
2025 Q2	$1.62M	Buy	3,991 +195	+5%	+$81.5K	0.08%	236
2025 Q1	$1.9M	Buy	3,796 +127	+3%	+$68.8K	0.08%	248
2024 Q4	$1.91M	Sell	3,669 -906	-20%	-$498K	0.07%	271
2024 Q3	$2.83M	Buy	4,575 +546	+14%	+$323K	0.12%	173
2024 Q2	$2.23M	Buy	4,029 +171	+4%	+$98K	0.08%	232
2024 Q1	$2.24M	Buy	3,858 +25	+0.7%	+$14K	0.09%	213
2023 Q4	$2.05M	Buy	3,833 +10	+0.3%	+$4.84K	0.11%	172
2023 Q3	$1.91M	Buy	3,823 +3,142	+461%	+$1.67M	0.1%	210
2023 Q2	$350K	Sell	681 -4,001	-85%	-$2.16M	0.05%	376
2023 Q1	$2.69M	Sell	4,682 -730	-13%	-$411K	0.14%	151
2022 Q4	$2.98M	Buy	5,412 +805	+17%	+$427K	0.14%	151
2022 Q3	$2.34M	Buy	4,607 +230	+5%	+$129K	0.14%	151
2022 Q2	$2.38M	Sell	4,377 -79	-2%	-$43.5K	0.14%	156
2022 Q1	$2.63M	Buy	4,456 +239	+6%	+$137K	0.1%	167
2021 Q4	$2.81M	Buy	+4,217	New	+$2.63M	0.1%	168

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ameritas Advisory Services's TMO Position: Q1 2026 in Review

Ameritas Advisory Services reduced its Thermo Fisher Scientific (TMO) stake by 2.3% in Q1 2026, selling an estimated $59.2K and leaving 4,674 shares worth $2.3M. The position accounts for 0.09% of the portfolio, ranked #205.

Ameritas Advisory Services first reported a position in TMO in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.98M in Q4 2022. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Ameritas Advisory Services held 4,674 shares of Thermo Fisher Scientific worth $2.3M as of Q1 2026.
Ameritas Advisory Services sold 109 Thermo Fisher Scientific shares in Q1 2026, an estimated $59.2K.
Thermo Fisher Scientific made up 0.09% of Ameritas Advisory Services's portfolio in Q1 2026, its #205 holding.
Ameritas Advisory Services first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 18 quarters since.
Ameritas Advisory Services's Thermo Fisher Scientific position peaked at $2.98M in Q4 2022.
2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Ameritas Advisory Services's 13F filing for Q1 2026, filed 12 May 2026.